Villalona-Calero, Miguel A <br/><br/>
Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors.  [electronic resource] 

 -  Cancer  Mar 2016 
 - 875-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.29856  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Disease-Free Survival<br/>ErbB Receptors--genetics<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Mammalian orthoreovirus 3<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplasm Recurrence, Local--drug therapy<br/>Oncolytic Virotherapy--methods<br/>Proto-Oncogene Proteins p21(ras)--genetics